daunorubicin has been researched along with Demyelinating Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appanraj, P; Chandar, R; Cs, G; Gopakumar, KG; Nair, M; Rajeswari, B; Seetharam, S; Thankamony, P | 1 |
| Benstead, TJ; Hayne, OA; McCormick, CW; Nevill, TJ | 1 |
2 other study(ies) available for daunorubicin and Demyelinating Diseases
| Article | Year |
|---|---|
Paraneoplastic Demyelinating Sensorimotor Neuropathy Delaying the Diagnosis of an Underlying Acute Lymphoblastic Leukemia in a Child.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain; Child; Daunorubicin; Demyelinating Diseases; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Male; Methotrexate; Paraneoplastic Syndromes, Nervous System; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Spine; Tomography, X-Ray Computed; Vincristine | 2018 |
Horner's syndrome and demyelinating peripheral neuropathy caused by high-dose cytosine arabinoside.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Demyelinating Diseases; Horner Syndrome; Humans; Leukemia, Promyelocytic, Acute; Male; Peripheral Nervous System Diseases | 1989 |